Patent ID: 9724422
Date: 2017-08-08
CPC Classifications: A61K,A61P,C07K

Claim:
1. A pharmaceutical composition, comprising: a supramolecular aggregate of a biological active substance and a human lactoferrin derived peptide, wherein the human lactoferrin derived peptide consists of the amino acid sequence of KCFQWQRNMRKVRGPPVSCIKR (SEQ ID NO: 1) or a sequence which is at least 90% homologous to SEQ ID NO: 1, wherein the biological active substance induces an undesired immune response by a mammalian organism, with an effect that after delivery of the pharmaceutical composition to the mammalian organism, there is no or only a diminished induction of the undesired immune response against the biological active substance, and wherein the biological active substance is in a sample of blood which is transfused to the mammalian organism.